165 related articles for article (PubMed ID: 33083704)
1. Pharmacist-Driven MRSA Nasal PCR Screening and the Duration of Empirical Vancomycin Therapy for Suspected MRSA Respiratory Tract Infections.
Woolever NL; Schomberg RJ; Cai S; Dierkhising RA; Dababneh AS; Kujak RC
Mayo Clin Proc Innov Qual Outcomes; 2020 Oct; 4(5):550-556. PubMed ID: 33083704
[TBL] [Abstract][Full Text] [Related]
2. Impact of a Pharmacist-driven Methicillin-resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Protocol on the De-escalation of Empiric Vancomycin in Patients with Pneumonia in a Rural Healthcare Setting.
Dadzie P; Dietrich T; Ashurst J
Cureus; 2019 Dec; 11(12):e6378. PubMed ID: 31938656
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of an electronic health system-based best-practice advisory to enhance the time to de-escalation of vancomycin for respiratory indications.
Gibbs AC; Jackson DA; Runjaic S; Toncray VJ; Bosch W; Mendez JC; Epps KL
Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e38. PubMed ID: 36310784
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist-Driven Methicillin-Resistant
Marinucci V; Louzon PR; Carr AL; Hayes J; Lopez-Ruiz A; Sniffen J
Ann Pharmacother; 2023 May; 57(5):560-569. PubMed ID: 36039495
[TBL] [Abstract][Full Text] [Related]
5. Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients with Suspected MRSA Pneumonia.
Baby N; Faust AC; Smith T; Sheperd LA; Knoll L; Goodman EL
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137813
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic de-escalation in pneumonia with pharmacist education and ordering of methicillin-resistant
Doan K; Smoke S
Eur J Hosp Pharm; 2024 Jun; 31(4):327-331. PubMed ID: 36754620
[TBL] [Abstract][Full Text] [Related]
7. Impact of a Pharmacist-Driven MRSA Nasal PCR Protocol on Pneumonia Therapy.
Pham SN; Sturm AC; Jacoby JS; Egwuatu NE; Dumkow LE
Hosp Pharm; 2021 Aug; 56(4):221-227. PubMed ID: 34381253
[No Abstract] [Full Text] [Related]
8. Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia.
Dunaway S; Orwig KW; Arbogast ZQ; Myers ZL; Sizemore JA; Giancola SE
Int J Clin Pharm; 2018 Jun; 40(3):526-532. PubMed ID: 29721739
[TBL] [Abstract][Full Text] [Related]
9. Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit.
Diep C; Meng L; Pourali S; Hitchcock MM; Alegria W; Swayngim R; Ran R; Banaei N; Deresinski S; Holubar M
Am J Health Syst Pharm; 2021 Dec; 78(24):2236-2244. PubMed ID: 34297040
[TBL] [Abstract][Full Text] [Related]
10. Impact of a pharmacist-driven methicillin-resistant
Willis C; Allen B; Tucker C; Rottman K; Epps K
Am J Health Syst Pharm; 2017 Nov; 74(21):1765-1773. PubMed ID: 29070498
[TBL] [Abstract][Full Text] [Related]
11. A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia.
Boyce JM; Pop OF; Abreu-Lanfranco O; Hung WY; Fisher A; Karjoo A; Thompson B; Protopapas Z
Antimicrob Agents Chemother; 2013 Mar; 57(3):1163-8. PubMed ID: 23254432
[TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment.
Sarikonda KV; Micek ST; Doherty JA; Reichley RM; Warren D; Kollef MH
Crit Care Med; 2010 Oct; 38(10):1991-5. PubMed ID: 20683260
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of the Methicillin-Resistant
Stodghill J; Finnigan A; Newcomb AB; Lita E; Liu C; Teicher E
Surg Infect (Larchmt); 2021 Nov; 22(9):889-893. PubMed ID: 33872057
[No Abstract] [Full Text] [Related]
14. Nasal-Swab Results for Methicillin-Resistant
Rioux J; Edwards J; Bresee L; Abu-Ulba A; Yu S; Dersch-Mills D; Wilson B
Can J Hosp Pharm; 2017; 70(2):107-112. PubMed ID: 28487577
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Negative Predictive Value of Methicillin-Resistant
Tai CH; Liu WL; Pan SC; Ku SC; Lin FJ; Wu CC
Infect Drug Resist; 2022; 15():1259-1266. PubMed ID: 35355623
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation Patterns and Cost Avoidance of a Pharmacist-Driven Methicillin-Resistant
Meng L; Pourali S; Hitchcock MM; Ha DR; Mui E; Alegria W; Fox E; Diep C; Swayngim R; Chang A; Banaei N; Deresinski S; Holubar M
Open Forum Infect Dis; 2021 Apr; 8(4):ofab099. PubMed ID: 34386545
[TBL] [Abstract][Full Text] [Related]
17. Clinical Utility of Methicillin-Resistant Staphylococcus aureus Nasal Screening for Antimicrobial Stewardship: A Review of Current Literature.
Carr AL; Daley MJ; Givens Merkel K; Rose DT
Pharmacotherapy; 2018 Dec; 38(12):1216-1228. PubMed ID: 30300441
[TBL] [Abstract][Full Text] [Related]
18. The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy in Intensive Care Unit Patients.
Chotiprasitsakul D; Tamma PD; Gadala A; Cosgrove SE
Infect Control Hosp Epidemiol; 2018 Mar; 39(3):290-296. PubMed ID: 29374504
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the reliability of MRSA screens in patients undergoing universal decolonization.
Chaudhry A; Allen B; Paylor M; Hayes S
Am J Health Syst Pharm; 2020 Nov; 77(23):1965-1972. PubMed ID: 32959059
[TBL] [Abstract][Full Text] [Related]
20. The Clinical Value of Methicillin-Resistant Staphylococcus aureus Nasal Screening in the Management of Diabetic Foot Infections.
Hosry J; Wang T; Assaad M; Kamel R; Homsy S; Sleiman E; Glaser A; Mobarakai NK
Int J Low Extrem Wounds; 2022 Sep; ():15347346221125332. PubMed ID: 36113032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
